Gables Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149K Sell
2,320
-100
-4% -$6.57K 0.05% 171
2026
Q1
$172K Hold
2,420
0.07% 146
2025
Q4
$198K Sell
2,420
-100
-4% -$7.79K 0.08% 133
2025
Q3
$189K Hold
2,520
0.08% 131
2025
Q2
$187K Hold
2,520
0.09% 128
2025
Q1
$203K Sell
2,520
-150
-6% -$12.9K 0.1% 126
2024
Q4
$209K Hold
2,670
0.1% 122
2024
Q3
$251K Buy
2,670
+2,597
+3,558% +$218K 0.13% 111
2024
Q2
$5.69K Hold
73
﹤0.01% 345
2024
Q1
$6.64K Hold
73
﹤0.01% 339
2023
Q4
$5.64K Hold
73
﹤0.01% 340
2023
Q3
$4.97K Hold
73
﹤0.01% 323
2023
Q2
$5.93K Hold
73
﹤0.01% 325
2023
Q1
$5.99K Buy
+73
New +$5.21K ﹤0.01% 323

Other funds holding GEHC

Gables Capital Management's GEHC Position: Q2 2026 in Review

Gables Capital Management reduced its GE HealthCare (GEHC) stake by 4.1% in Q2 2026, selling an estimated $6.57K and leaving 2,320 shares worth $149K. The position accounts for 0.05% of the portfolio, ranked #171.

Gables Capital Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $251K in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Gables Capital Management held 2,320 shares of GE HealthCare worth $149K as of Q2 2026.
  • Gables Capital Management sold 100 GE HealthCare shares in Q2 2026, an estimated $6.57K.
  • GE HealthCare made up 0.05% of Gables Capital Management's portfolio in Q2 2026, its #171 holding.
  • Gables Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Gables Capital Management's GE HealthCare position peaked at $251K in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Gables Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.